Page 2 - Christopher Schott News Today

IntegriChain Regulatory Experts to Speak at Informas Medicaid and GP Congress News provided by Share this article Share this article PHILADELPHIA, May 27, 2021 /PRNewswire/ -- IntegriChain, delivering Life Sciences only comprehensive data and business process platform for market access, today announced that two senior Advisory experts will present at Informas upcoming Rupal Patel, Senior Director, are both experts in the latest regulatory landscape affecting Contracts & Pricing teams, advisin...

RPRX earnings call for the period ending March 31, 2021.

UpdatedSun, Apr 25, 2021 at 10:47 pm CT Reply The city of Joliets board of police and fire commissioners rejected Police Chief Dawn Malecs recommendation to promote Sgt. Chris Schott to a lieutenant last week. (City of Joliet) JOLIET, IL — A Joliet police supervisor being recommended for promotion to lieutenant was rejected in a 3-0 vote at last Thursdays meeting of the citys board of police and fire commissioners. Joliet Police Sgt. Christopher Schott was turned down in his bid to become e...

Pfizer Inc. projected about $15 billion in revenue this year from the Covid-19 vaccine it developed with BioNTech SE, but the shares fell amid questions about the durability of the market for the shot.

Pfizer Projects $15 Billion in 2021 Sales of Covid Vaccine Bloomberg 2/2/2021 Riley Griffin (Bloomberg) -- Pfizer Inc. projected about $15 billion in revenue this year from the Covid-19 vaccine it developed with BioNTech SE, but the shares fell amid questions about the durability of the market for the shot. Company officials led by Chief Executive Albert Bourla said on a conference call that the vaccine looks capable of taking on new variants, its price may increase and new pr...

Share it The second day of the J.P. Morgan Healthcare Conference didnt bring any billion-dollar acquisitions or high-priced partnerships. But the light slate of news felt a little less existential than might be expected for a meeting that prides itself on market-moving developments. Biotech stock indices continue to do well, boosted by a stretch of dealmaking that closed out 2020. Venture and IPO fundraising hit record highs last year. And the industry is one month removed from the success of c...